SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 59 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $6,000 | -14.3% | 11,416 | -5.9% | 0.00% | – |
Q1 2016 | $7,000 | -65.0% | 12,134 | -45.8% | 0.00% | – |
Q4 2015 | $20,000 | -23.1% | 22,385 | -28.2% | 0.00% | – |
Q3 2015 | $26,000 | -21.2% | 31,185 | +180.9% | 0.00% | – |
Q2 2015 | $33,000 | -77.4% | 11,100 | -81.3% | 0.00% | – |
Q1 2015 | $146,000 | +595.2% | 59,454 | +632.0% | 0.00% | – |
Q4 2014 | $21,000 | -97.5% | 8,122 | -93.1% | 0.00% | -100.0% |
Q3 2014 | $836,000 | -39.7% | 117,032 | -45.0% | 0.00% | 0.0% |
Q2 2014 | $1,387,000 | +950.8% | 212,821 | +963.0% | 0.00% | – |
Q1 2014 | $132,000 | +25.7% | 20,021 | -9.4% | 0.00% | – |
Q4 2013 | $105,000 | -34.4% | 22,100 | -31.5% | 0.00% | – |
Q3 2013 | $160,000 | -17.5% | 32,274 | -13.2% | 0.00% | – |
Q2 2013 | $194,000 | – | 37,176 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |